The complete beta launch experience, known as the Beta Complete Journey, includes a baseline total body DEXA scan, a year of Bondia™ capsules, and access to an accompanying mobile app.BOSTON, May 8, 2024 /PRNewswire/ -- All peri- and postmenopausal women experience bone loss, which can lead to osteoporosis if left unmanaged.

完整的测试版发布体验，即所谓的测试版完整旅程，包括基线全身DEXA扫描，一年的Bondia™胶囊，以及访问附带的移动应用程序。波士顿，2024年5月8日/PRNewswire/--所有围绝经期和绝经后女性都会出现骨质流失，如果不加以管理，可能导致骨质疏松症。

And although osteoporosis is exceedingly common, afflicting 1 in 3 women, most are unaware of their condition and the implications that it can have for their health. An osteoporotic injury can be devastating, significantly reducing quality of life and—in the worst cases—resulting in a 30% mortality rate in the first-year post-hip fracture..

尽管骨质疏松症非常常见，每三名女性中就有一名患有骨质疏松症，但大多数人不知道自己的病情以及它对健康的影响。骨质疏松性损伤可能具有破坏性，会显着降低生活质量，在最坏的情况下，会导致髋部骨折后第一年的死亡率达到30%。。

Solarea Bio, a Boston-based clinical-stage biotechnology company, recognizes this and believes that it is essential to not only raise awareness around the importance of bone health far ahead of menopause, but to also provide consumers with tangible avenues for managing bone loss leading up to and throughout the menopausal experience..

位于波士顿的临床阶段生物技术公司Solarea Bio认识到这一点，并认为至关重要的是，不仅要在更年期之前提高人们对骨骼健康重要性的认识，还要为消费者提供切实可行的途径来管理绝经前和整个绝经期间的骨质流失。。

Solarea Bio develops health innovations using fruit and vegetable-derived microbes, and is launching its consumer health brand, Journa, to bring these products to market. Initially debuting via a private beta program, their first-ever product, Bondia™ medical food, is a daily synbiotic capsule that helps address bone loss in peri- and postmenopausal women.

Solarea Bio利用水果和蔬菜衍生的微生物开发健康创新，并推出其消费者健康品牌Journa，将这些产品推向市场。他们的第一款产品Bondia™medical food最初是通过私人测试计划推出的，它是一种每日服用的合生元胶囊，有助于解决围绝经期和绝经后妇女的骨质流失问题。

It is naturally formulated and being clinically validated to address bone loss through the dietary management of the condition. This private beta program serves as a prelaunch trial to evaluate the overall customer experience with the rollout—such as with orders, shipping, and app usage—in advance of its anticipated public launch this September..

它是天然配制的，并经过临床验证，可通过饮食管理来解决骨质流失问题。这项私人测试计划是一项启动前试验，旨在评估在预计于今年9月公开发布之前，客户在订单、发货和应用程序使用等方面的整体体验。。

Bondia™ medical food is Journa's naturally developed, clinical solution to manage postmenopausal bone loss. The daily synbiotic medical food is formulated using a blend of fruit and vegetable-derived probiotic bacteria, yeast, and prebiotic plant fibers aimed at reducing the inflammation and activity of osteoclasts, the cells that break down bone as part of normal bone maintenance.

Bondia™医疗食品是Journa自然开发的临床解决方案，用于管理绝经后骨质流失。每日合生元医疗食品是使用水果和蔬菜衍生的益生菌，酵母和益生元植物纤维的混合物配制而成的，旨在减少破骨细胞的炎症和活性，破骨细胞是破坏骨骼的细胞，是正常骨骼维持的一部分。

In preparation for its private beta program, Bondia™ medical food is currently undergoing a double-blind, placebo-controlled clinical food trial in 286 early postmenopausal women. Adds Eric Schott, PhD, the COO and co-founder of Solarea Bio, 'Bondia™ has been extensively characterized using in vitro, in vivo, preclinical models, and rigorous randomized clinical food trials in partnership with leading institutions and now is ready to be tested by customers.

为了准备其私人测试计划，Bondia™医疗食品目前正在286名绝经后早期女性中进行双盲，安慰剂对照的临床食品试验。Solarea Bio首席运营官兼联合创始人Eric Schott博士补充道，“Bondia™已与领先机构合作，通过体外，体内，临床前模型和严格的随机临床食品试验进行了广泛表征，现在已经准备好接受客户的测试。

The product is Generally Recognized as Safe (GRAS) and has an excellent tolerability profile.'Selected beta participants will have the ability to take the Bondia™ medical food for free throughout the two month duration of the program, and will have the opportunity to record their beta experience and receive guidance in the accompanying Journa mobile app.

该产品通常被认为是安全的（GRAS），并且具有良好的耐受性。”选定的测试参与者将能够在整个项目的两个月期间免费服用Bondia™医疗食品，并有机会记录他们的测试体验，并在附带的Journa移动应用程序中获得指导。

Participants who want a more comprehensive regimen can express interest in the full beta experience, known as the Complete Beta Journey, comprising a 12 month supply of Bondia™ and extended access to the Journa app. Through Journa's partnership with DexaFit, and its location in the San Francisco Bay area, selected Complete Beta Journey participants will also receive a complimentary full body DEXA scan, a cutting-edge evaluation for assessing bone mineral density (BMD) as well as muscle and fat composition, at the start and end of the program.

想要更全面方案的参与者可以对完整的测试体验表示兴趣，称为完整的测试旅程，包括12个月的Bondia™供应和Journa应用程序的扩展访问。通过Journa与DexaFit的合作关系及其在旧金山湾区的位置，选定的完整测试旅程参与者还将获得免费的全身DEXA扫描，这是一项在项目开始和结束时评估骨矿物质密度（BMD）以及肌肉和脂肪组成的前沿评估。

'Tracking BMD, muscle, and fat will empower wome.

“追踪骨密度、肌肉和脂肪将赋予女性力量。